About

Sapporo Medical Journal

Sapporo Medical Journal is an open access, monthly, peer reviewed International Medical Journal with focuses on publishes research conducted in all fields of medical, medicine. There is no restriction on the length of research papers and reviews, although authors are encouraged to be concise. Sapporo Medical Journal is a scopus indexed International Medical Journal that wants to publish original articles, research articles, review articles with top-level work from all areas of Medicine, General Medicine, Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody etc.
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal

Sapporo Medical Journal aims to distribute and expand medical data to the World as well as build a supportive and vibrant community of researchers to connect and explore ideas by publishing articles related to all fields of medicine. Sapporo Medical Journal believes that quality and ethical research. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Medicine Microbiology Biochemistry Pharmacology Pathology Forensic medicine Internal Medicine Physiology Anatomy Obstetrics and Gynecology Radiology Community Medicine Otorhinolaryngology Infectious Diseases General Surgery Cancer research Pulmonary Dermatology and Venereal diseases Orthopedics Neurology Anaesthesia Medical education Infectious Diseases and Vaccinology Neurosurgery Gastroenterology Nephrology Paediatrics Reproduction Dental Cardiology Surgery Nursing Otolaryngology Dermatology Diabetes Orthopaedics Hepatology Urology Psychology Anesthesiology Endocrinology Biotechnology Venereology ENT Psychiatry Pharmaceutical Analysis Pharmacy Pharmaceutical Chemistry Pulmonology Pharmaceutics Pharmaceutical Pharmacognosy Biopharmaceutics Phatmaceutical Technology Quality Assurance Pharmacodynamics Pharmacokinetics Drug Regulatory Industrial Pharmacy Pharmaceutical Nanotechnology Drug Design Affairs Phytochemistry Drug Delivery Systems Drug Discovery Pharmaceutical Microbiology Pharmacy Practice Hospital Pharmacy Clinical Pharmacy Pharmacogenomics Drug Metabolism Pharmacovigilance Toxicology Clinical Research Microbiology Phrmacoinformatics Life Sciences like Chemistry Epidemiology Biomedical Sciences Immunology Dentistry Oncology Biomedicine Physiotherapy Sexology Neuroscience Gynaecology Dermatoepidemiology Pharmacy and Nursing Angiology/Vascular Medicine Osteology Ophthalmology Haematology Kinesiology Critical care Medicine Pharmacognosy and Phytochemistry Clinical immunology Bariatrics Genomics and Proteomics Clinical and Hospital Pharmacy Radiobiology Cell Biology Geriatric Medicine Healthcare Services Healthcare Management Bioinformatics and Biotechnology
Paper ID : SMJ1107215507316

Abstract : Essential hypertension and its complication, a chronic heart failure, are one of the most common pathological tandems in practical cardiology. Linked etiologically and pathogenetically, they share a common path of progression, manifested by structural, functional, and humoral disturbances in cardiovascular homeostasis. In recent years, a member of the family of natriuretic peptides, brain natriuretic peptide, has taken the place of one of the biomarkers of myocardial and vascular remodeling processes, most often used in practical medicine; it is also positioned as a humoral antagonist of the activity of renin-angiotensin-aldosterone system, which is the leading pathogenetic link in most cases of hypertensive cascade and CHF. This study aims to supplement the data on the use of BNP as a signaling indicator of changes in myocardial structure and function and calculate the screening threshold levels of peptide in uncomplicated and complicated EH in postmenopausal women with polymorphic variants of the BNP gene. It was revealed that the frequency of carrying the T381C genotype and the C allele significantly prevails among the polymorphic variants of the BNP gene in women 40-65 years of age. The highest level of plasma BNP concentration, which was 193,27 ± 2,98 pg/ml, was determined in women with EH complicated by CHF. In addition, carrying the C allele of the BNP gene is significantly associated with higher levels of peptide in the blood plasma of women in all the examined groups

Paper ID : SMJ0807215507313
Sapporo Medical Journal
Author : Dhihintia Jiwangga Suta Winarno, Rafaela Andira Ledyastatin, Caesario Tri Prasetyo,

Abstract : Background: Renal failure is one of the most common diseases and might develop to the end-stage level in which need to have hemodialysis to survive. Generally, Arteriovenous Fistula (AVF) created for hemodialysis access and its maturity depends on several factors, including hand exercise. This study aims to evaluate the implications of hand exercises in the process of AVF maturation in patients with chronic kidney failure. Methods: Performing literature search using Pubmed, The Cochrane, and Google Scholar databases were done from 2015 to 2019. All case series, cohort studies, and clinical trials were considered if they met inclusion criteria. Result: From 603 studies, five studies were met inclusion criteria. Four studies showed hand exercises with different protocols from each study. The outcome parameter was varied throughout all the studies. Hand exercise has believed to have a potential effect on AVF maturation. Through ultrasonographic value, diverse findings in the outcome such as arterial and vein diameter and increasing of blood flow measured. One study had assessed clinical maturation in AVF as one of the outcomes of the study. Nevertheless, one study showed no significant effect of hand exercise in ultrasonographic maturation. Conclusion: Hand exercises with different types of exercises can make changes in AVF maturation parameters. However, it needs further accessible evidence study with the same exercise protocol and evaluation so that the effect of t

Paper ID : SMJ0807215507312

Abstract : Purpose: To identify various perioperative factors that could affect early mortality in Tetralogy of Fallot (TF) patients after the total correction procedure. Method: This retrospective cohort study used a cross-sectional design using secondary data from medical records of TF patients who underwent total correction procedures at Dr. Soetomo Academic General Hospital, Surabaya, Indonesia from August to September 2019. The study outcomes were a single risk factor or concomitant risk factor that affected the mortality rate during post-total correction treatment of TF patients. Results: Forty-two patients undergoing total repair surgery during the study period, this study had a mortality rate of 33.3% (14 patients). Univariate analysis reveals factors influencing mortality namely age <24 months (OR=15.0, p=0.02), weight <10 kgs (OR=6.25, p=0.025), SaO2 <75% (OR=12.833, p=0.013), HCT >65% (OR=4.5, p=0.049), ventilator time >48 hours (OR=4.5, p=0.031), Fever (OR=50, p=<0.001), residual PS (OR=14, p=0.021), residual VSD (OR=16.1, p=0.003), VIS (OR=59.8, p=<0.001). Conclusion: In our study, we found variables that influenced mortality rate in univariate analysis. A cardiac surgeon can take this into contemplation while choosing the best option for the patient by seeing these perioperative factors to reduce the mortality rate in TF cases after total repair. Keywords: Mortality rate, Perioperative Factors, Tetralogy of Fallot, Total Correction

Paper ID : SMJ0707215507310

Abstract : Background: Candida the most mutual source of urinary tract infection (UTI) as an opportunistic pathogen. Risk factors like: diabetes mellitus, pregnancy, steroids and hospitalization can promote candiduria. This study aimed to evaluates candiduria in pregnant women and their relation to social and physiological parameters. Method: Across sectional analytical study extended all over 2019 (January till December) to recruit 510 ladies, done in Bint Al-Huda public hospital- and Al-Rahman gynecology and obstetrics private hospitals Thi-Qar-Southern of Iraq, where specific age criteria that extended from 14 years till 55 years with mean age of 29±7.56 years. Results: The results showed significant differences (p <0.05) in the presence of bacterial and fungal infections in a female under this study. While, there is no relations between both groups of female in pH value of urine. The presence of fungal infections was not correlated with the types of blood groups and jobs of infected women under (P > 0.05). Conclusion: It was noted through the study that the rate of urinary tract infections with Candiduria in Iraqi women is one of the relatively low rates in the world and is mainly affected by the state of immune debility during pregnancy and related to bacterial infections with no relationship to the urine pH, types of blood groups and the type of work with the rates of occurrence of this type of infections.

Paper ID : SMJ0707215507309
Sapporo Medical Journal
Author : • Sajjad H. Kadhim Al-Shuwailli, • Munib Ahmed Al-Zubaidi, • Dawood S. Abdoun,

Abstract : Background: The primary goal of central precocious puberty treatment is to preserve final adult height. Safe and effective treatment of central precocious puberty in the form of long-acting GnRH analogs has been available for many years. Aim of study: To study the clinical characters of patients with central precocious puberty and their response to GnRh agonist therapy. Patients and Method: A randomized clinical trial study that conducted at Pediatric Endocrinology Outpatient Clinic in Children Welfare Teaching Hospital / Medical City from 1st of November 2018 to 30th of October 2019. It included 83 patients presented to the hospital because of early pubertal development and diagnosed with central precocious puberty. Subcutaneous injections of GnRH agonist (goserelin acetate [Zoladex]) were administered to all patients. Patients were observed for weight, height and sex maturation rate in addition to laboratory data were taken after at least 12 months. Results: In this study, there were significant decrease in height, suppression of the significant increase in bone age, and a significant increase in BMI level after treatment compared to that before treatment. Basal LH, FSH estradiol & testosterone values after treatment decline to significant levels. Conclusion: GnRHa treatment for CPP is safe and can be curative by improving the predicted height and delaying the growth rate.